CAD 4.07
(-7.08%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -657.26 Million CAD | 80.14% |
2022 | -3.3 Billion CAD | -932.67% |
2021 | -320.48 Million CAD | 80.82% |
2020 | -1.67 Billion CAD | -20.42% |
2019 | -1.38 Billion CAD | -107.05% |
2018 | -670.09 Million CAD | -1137.84% |
2017 | -54.13 Million CAD | -225.97% |
2016 | -16.6 Million CAD | -375.03% |
2015 | -3.49 Million CAD | 60.86% |
2014 | -8.93 Million CAD | -857.35% |
2013 | -932.92 Thousand CAD | -1343.98% |
2012 | -64.6 Thousand CAD | -202.01% |
2011 | -21.39 Thousand CAD | 11.11% |
2010 | -24.06 Thousand CAD | 10.59% |
2009 | -26.91 Thousand CAD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -127.13 Million CAD | -37.69% |
2023 Q1 | -38.12 Million CAD | 94.11% |
2023 Q2 | -310.01 Million CAD | -713.24% |
2023 Q3 | -216.79 Million CAD | 30.07% |
2023 Q4 | -92.33 Million CAD | 57.41% |
2023 FY | -657.26 Million CAD | 80.14% |
2022 Q2 | -231.91 Million CAD | 88.89% |
2022 Q1 | -2.08 Billion CAD | -260.79% |
2022 Q3 | -266.72 Million CAD | -15.01% |
2022 Q4 | -647.6 Million CAD | -142.8% |
2022 FY | -3.3 Billion CAD | -932.67% |
2021 Q2 | -11.05 Million CAD | -102.82% |
2021 FY | -320.48 Million CAD | 80.82% |
2021 Q1 | 392.41 Million CAD | 156.06% |
2021 Q3 | -115.49 Million CAD | -944.46% |
2021 Q4 | -578.61 Million CAD | -400.98% |
2020 Q3 | -904.38 Million CAD | -2720.81% |
2020 Q1 | -108.5 Million CAD | -123.75% |
2020 Q2 | -32.06 Million CAD | 70.45% |
2020 FY | -1.67 Billion CAD | -20.42% |
2020 Q4 | -699.97 Million CAD | 22.6% |
2019 Q4 | 456.88 Million CAD | 477.69% |
2019 Q1 | -1.28 Billion CAD | -282.31% |
2019 Q2 | -374.18 Million CAD | 70.84% |
2019 Q3 | -120.96 Million CAD | 67.67% |
2019 FY | -1.38 Billion CAD | -107.05% |
2018 Q2 | -337.13 Million CAD | -319.97% |
2018 Q4 | -335.6 Million CAD | -596.59% |
2018 Q3 | 67.58 Million CAD | 120.05% |
2018 Q1 | -80.27 Million CAD | -30.44% |
2018 FY | -670.09 Million CAD | -1137.84% |
2017 Q2 | -1.33 Million CAD | 69.06% |
2017 Q3 | 1.58 Million CAD | 218.31% |
2017 FY | -54.13 Million CAD | -225.97% |
2017 Q1 | -4.32 Million CAD | 79.49% |
2017 Q4 | -61.54 Million CAD | -3987.81% |
2016 FY | -16.6 Million CAD | -375.03% |
2016 Q4 | -21.08 Million CAD | -804.55% |
2016 Q3 | 2.99 Million CAD | -44.9% |
2016 Q2 | 5.43 Million CAD | 237.5% |
2016 Q1 | -3.94 Million CAD | 22.9% |
2015 FY | -3.49 Million CAD | 60.86% |
2015 Q3 | -3.31 Million CAD | -184.39% |
2015 Q4 | -5.12 Million CAD | -54.46% |
2015 Q2 | 3.92 Million CAD | 288.38% |
2015 Q1 | 1.01 Million CAD | 177.72% |
2014 Q4 | -1.3 Million CAD | 50.66% |
2014 FY | -8.93 Million CAD | -857.35% |
2014 Q1 | -1.16 Million CAD | 57.9% |
2014 Q3 | -2.63 Million CAD | -11.01% |
2014 Q2 | -2.37 Million CAD | -104.82% |
2013 Q4 | -2.75 Million CAD | -9674.74% |
2013 FY | -932.92 Thousand CAD | -1343.98% |
2013 Q1 | -37.75 Thousand CAD | -667.75% |
2013 Q2 | -7269.00 CAD | 80.75% |
2013 Q3 | -28.19 Thousand CAD | -287.92% |
2012 Q3 | -11.92 Thousand CAD | 42.93% |
2012 FY | -64.6 Thousand CAD | -202.01% |
2012 Q2 | -20.89 Thousand CAD | -753.59% |
2012 Q4 | -4918.00 CAD | 58.76% |
2012 Q1 | -2448.00 CAD | 67.59% |
2011 Q3 | -8984.00 CAD | -273.09% |
2011 Q1 | -377.00 CAD | 95.01% |
2011 Q2 | -2408.00 CAD | -538.73% |
2011 Q4 | -7554.00 CAD | 15.92% |
2011 FY | -21.39 Thousand CAD | 11.11% |
2010 Q1 | -138.00 CAD | 98.43% |
2010 Q4 | -7548.00 CAD | 43.0% |
2010 FY | -24.06 Thousand CAD | 10.59% |
2010 Q3 | -13.24 Thousand CAD | -356.66% |
2010 Q2 | -2900.00 CAD | -2001.45% |
2009 Q2 | - CAD | 0.0% |
2009 FY | -26.91 Thousand CAD | 0.0% |
2009 Q3 | -18 Thousand CAD | 0.0% |
2009 Q4 | -8777.00 CAD | 51.25% |
Name | Net Income | Net Income Difference |
---|---|---|
Aurora Cannabis Inc. | -69.32 Million CAD | -848.084% |
Avicanna Inc. | -8.74 Million CAD | -7417.657% |
Avant Brands Inc. | -5.07 Million CAD | -12863.886% |
Cardiol Therapeutics Inc. | -28.12 Million CAD | -2236.683% |
Crescita Therapeutics Inc. | -1.98 Million CAD | -32995.116% |
Knight Therapeutics Inc. | -16.83 Million CAD | -3804.182% |
MediPharm Labs Corp. | -13.08 Million CAD | -4923.84% |
OrganiGram Holdings Inc. | -229.47 Million CAD | -186.419% |
Willow Biosciences Inc. | -13.02 Million CAD | -4944.662% |
Auxly Cannabis Group Inc. | -44.51 Million CAD | -1376.644% |